Glenmark launches antidiabetic drug in India

​​ The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the company said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jv0c7Et
via IFTTT